Key result
Moderate PVL after TAVI is linked to ~21% higher mortality, whereas mild PVL is not.
Why the study?
Severe paravalvular leakage (PVL) after transcatheter aortic valve implantation (TAVI) is known to increase mortality, but the clinical significance of mild and moderate PVL on mortality remains uncertain.
Does mild and moderate paravalvular leakage increase mortality in patients undergoing transcatheter aortic valve implantation?
Cohort (n=14,296)
Yes
Does mild and moderate paravalvular leakage increase mortality in patients undergoing transcatheter aortic valve implantation?
Answers are grounded in this paper and cite their sources.
Moderate paravalvular leakage after TAVI is associated with increased mortality mainly during the first years post-procedure, whereas mild paravalvular leakage does not significantly impact survival.
Background Transcatheter aortic valve implantation (TAVI) has become the most common aortic valve replacement method for aortic stenosis. A known complication after valve replacement is paravalvular leakage (PVL). Severe PVL has been shown to increase mortality, but the significance of minor PVL remains uncertain. The aim of this retrospective observational cohort study was to investigate the clinical significance of mild and moderate PVL on mortality. Methods This study was based on data from the Swedish transcatheter cardiac intervention registry (SWENTRY) and included 14 296 patients undergoing TAVI during the years 2008–2025. SWENTRY was combined with the Swedish population registry to obtain survival data. Multivariate cox proportional hazards regression was used to analyse survival, where patients with mild and moderate PVL after TAVI were compared to patients with no PVL after TAVI. Landmark analyses from 30 days, 1 year and 5 years were performed to verify the effect of PVL on survival across varying post-surgical time-periods. Results Moderate PVL was associated with a significant higher hazard of mortality (HR 1.21, 95% CI [1.07–1.38], p=0.003). The results were consistent in the 30-day-landmark analysis (HR 1.16, 95% CI [1.02–1.32], p=0.027), but not in the other landmark analyses. Mild PVL was not associated with a statistically significantly higher hazard of mortality in any of the analyses (HR 1.05, 95% CI [0.99–1.11], p=0.107). Conclusions The results indicate that mild PVL does not have a statistically significant adverse effect on mortality. However, moderate PVL seems to have a more pronounced negative impact on survival, which should not be disregarded. This adverse effect seems to occur mainly during the first years after TAVI. These results indicate that mild PVL is presumably not associated with increased mortality, as well as highlight the clinical relevance of moderate PVL and imply that further attention to its management might be needed.
No takes yet. Share an insight, caveat, or question.
Lofgren et al. (2026) conducted a cohort in Aortic stenosis treated with transcatheter aortic valve implantation (TAVI) (n=14,296). Moderate or mild paravalvular leakage (PVL) after TAVI vs. No paravalvular leakage after TAVI was evaluated on All-cause mortality (HR 1.21, 95% CI 1.07-1.38, p=0.003). Moderate paravalvular leakage after TAVI increased mortality risk, whereas mild leakage did not.
Synapse has enriched 10 related papers. Consider them for comparative context: